Results
271 - 280 of 430 results for ‘standards’.
-
Immunisation indication values
http://corporat-prod.sites.silverstripe.com/for-health-providers/claims-provider-payments-and-entitlements/immunisation-subsidy/immunisation-indication-values
Understand 'indications' 'Immunisation indication values' or 'indications' that Sector Operations staff may refer to are t he reasons that vaccines are administered. The scheduled reason, for example 6 weeks, is used to report where the vaccination falls on the NZ vaccination schedule. Refer to the table below for the indication value that Sector Operations staff refer to and the description which is what the provider will most likely see on their screen. Immunisation indication values Immunisation indication values Indication value Description 1 Over 65 years (Influenza) 2 Under 18
-
Typhoid and paratyphoid fever
http://corporat-prod.sites.silverstripe.com/for-health-professionals/clinical-guidance/communicable-disease-control-manual/typhoid-and-paratyphoid-fever
... of source Identification of source Check for other cases in the community or at-risk groups. Investigate potential food or water sources of infection in all cases. If indicated, check water supply for microbiological contamination and compliance with the latest New Zealand drinking-water standards (Ministry of Health 2008). If a water supply is involved, liaise with the local territorial authority to inform the public. Advise on the need to boil water. Disinfection Disinfection Clean and disinfect surfaces and articles soiled with stool or urine. For further details, refer to Appendix 1 ...
-
Plague
http://corporat-prod.sites.silverstripe.com/for-health-professionals/clinical-guidance/communicable-disease-control-manual/plague
Chapter last reviewed and updated in May 2012. Epidemiology Expand all New Zealand Epidemiology New Zealand Epidemiology Twenty-one cases of plague were recorded in New Zealand between 1900 and 1911, but none has been recorded since then. However, both species of rodent flea necessary for the transmission of the plague bacteria Yersinia pestis exist in New Zealand. More detailed epidemiological information is available on the Institute of Environmental Science and Research (ESR) surveillance website (external link) . Case definition Expand all Clinical description Clinical description A
-
Tuberculosis
http://corporat-prod.sites.silverstripe.com/for-health-professionals/clinical-guidance/diseases-and-conditions/tuberculosis
Tuberculosis (TB) control in the 21st century faces many challenges at the global, regional and national level. The problems of poverty, adherence to treatment and stigma still prevail, while increasing drug resistance and HIV co-infection demand new approaches. Due to a number of manufacturing issues which have affected global vaccine supplies, BCG vaccine was not available in New Zealand between 2016 and mid 2018. The vaccine is now available from public health community BCG vaccination clinics and in-hospital vaccinations. For more information see BCG vaccine
-
Antimicrobial prescribing guidance and antibiograms
http://corporat-prod.sites.silverstripe.com/for-health-professionals/clinical-guidance/diseases-and-conditions/antimicrobial-resistance/antimicrobial-prescribing-guidance-and-antibiograms
A team of clinicians and researchers is working collaboratively across the motu to merge the guidelines below into a single national prescribing standard to support effective, equitable and sustainable antimicrobial use for Aotearoa New Zealand. Find out more about this mahi and the team: Our projects - Antibiotic Conservation Aotearoa (external link) The team anticipate launching the national guidelines in 2025. For further information, please contact antimicrobials@cdhb.health.nz . Guidance for community prescribing For guidance for community prescribing read the 2017 edition o
-
Spinal muscular atrophy (SMA)
http://corporat-prod.sites.silverstripe.com/health-services-and-programmes/newborn-metabolic-screening-programme/spinal-muscular-atrophy
About spinal muscular atrophy (SMA) Spinal muscular atrophy (SMA) is a rare inherited neurogenetic condition which affects the motor nerves in the spinal cord (motor neurons), causing muscle weakness. Babies may look healthy at birth, but as motor nerves are lost, the muscles become weak, causing difficulties with motor development, breathing and swallowing. SMA is caused by a mutation in both copies of the SMN1 gene. It is caused by a missing or faulty gene called the SMN1 gene. Babies usually received two copies of this gene – one from each parent. A p
-
Screening for severe combined immune deficiency
http://corporat-prod.sites.silverstripe.com/health-services-and-programmes/newborn-metabolic-screening-programme/screening-for-severe-combined-immune-deficiency
Expand all What is SCID? What is SCID? Severe combined immune deficiency (SCID) is a rare inherited disorder caused by a deficiency or absence of T cells, a type of lymphocyte that plays a central role in immunity. This results in babies having little or no immune response. Babies born with SCID appear healthy at first, but are extremely vulnerable to recurrent infections. The symptoms of SCID include recurrent life-threatening infections, failure to thrive, diarrhea and thrush. The average age of diagnosis is approximately six months. If not treated, most babies with SCID do not survive past
-
Whaihua
http://corporat-prod.sites.silverstripe.com/health-services-and-programmes/digital-health/whaihua
What is Whaihua? Whaihua is a digital interface that allows health providers to view information held in Health New Zealand registers, the Book My Vaccine tool and also record newborn enrolments. Whaihua was launched in December 2023 and will continue to develop functionality based on feedback from users and strategic priorities as the health system in New Zealand builds towards long term interoperability. What providers should use Whaihua? Providers who are working in assisted channels, support or outreach activities can utilise Whaihua’s current functionality. As Whaihua continues to be de
-
BCG vaccine and vaccinator endorsement
http://corporat-prod.sites.silverstripe.com/health-services-and-programmes/vaccine-information/vaccine-service-delivery/bcg-vaccine-and-vaccinator-endorsement
... professional responsibility to ensure they apply for the appropriate regional endorsement(s). BCG endorsement is valid for up to two years from the completion of the BCG vaccinator training. All vaccinators must at all times adhere to best practice as outlined in the ‘ Immunisation Standards for Vaccinators (external link) ’ in Immunisation Handbook. Tuberculosis, Mantoux Skin Testing and BCG Vaccinator Update Online Course The Ministry-approved online course Tuberculosis, Mantoux Skin Testing and BCG Vaccinator Update is available through the Immunisation Advisory Centre ...
-
Nursing — Wellington, Hutt and Kapiti
http://corporat-prod.sites.silverstripe.com/for-health-professionals/health-workforce-development/district-and-regional/wellington-hutt-and-kapiti/nursing
... Wellington, Hutt and Kapiti align the progression with PDRP requirements, and identify pathways that will support consistent practice in all practice areas across the region align the professional development of enrolled nurses with the new scope of practice and Nursing Council of New Zealand standards of competence clarify expectations and access to professional development by providing a consistent pathway of professional development support policy development within Wellington, Hutt and Kapiti to include enrolled nurses. More information Enrolled nurse professional development pathway [PD ...